Angewandte
Chemie
[1]a) T. Mori, K. Takahashi, M. Kashiwabara, D.
Uemura, Tetrahedron Lett. 1985, 26, 1073 –
1076; b) K. Takahashi, M. Kawabata, D.
Uemura, Tetrahedron Lett. 1985, 26, 1077 –
1078.
[2]For a review, see M. G. Moloney, P. C. Trippier,
M. Yaqoob, A. Wang, Curr. Drug Discovery
Technol. 2004, 1, 181 – 199.
[3]a) T. J. Donohoe, J. Y. K. Chiu, R. E. Thomas,
Org. Lett. 2007, 9, 421 – 424; N. J. Bennet, J. C.
Prodger, G. Pattenden, Tetrahedron 2007, 63,
6216 – 6231, and references therein.
[4]A. S. Kende, K. Kawamura, R. J. DeVita, J. Am.
Chem. Soc. 1990, 112, 4070 – 4072.
[5]T. Harada, T. Mukaiyama, Chem. Lett. 1982,
161 – 164.
[6]J. K. Stille, B. L. Groh, J. Am. Chem. Soc. 1987,
109, 813 – 817.
[7]a) H. Jin, J. Uenishi, W. J. Christ, Y. Kishi, J.
Am. Chem. Soc. 1986, 108, 5644 – 5646; b) K.
Takai, M. Tagashira, T. Kuroda, K. Oshima, K.
Utimoto, H. Nozaki, J. Am. Chem. Soc. 1986,
108, 6048 – 6050.
[8]For a review, see I. Ojima, Z. Li, J. Zhu in The
Chemistry ofOrganic Silicon Compounds
,
Vol. 2 (Eds.: Z. Rappoport, Y. Apeloig),
Wiley, New York, 1998, pp. 1687 – 1792.
[9]K. Tamao, K. Maeda, T. Tanaka, Y. Ito,
Tetrahedron Lett. 1988, 29, 6955 – 6956.
[10]B. M. Trost, J. P. N. Papillon, J. Am. Chem. Soc.
2004, 126, 13618 – 13619.
[11]A. Abiko, O. Moriya, S. A. Filla, S. Masamune,
Angew. Chem. 1995, 107 869 – 871; Angew.
Chem. Int. Ed. Engl. 1995, 34, 793 – 795.
[12]S. E. Denmark, W. Pan, Org. Lett. 2001, 3, 61 –
64.
Scheme 3. Completion of the total synthesis of neooxazolomycin: a) KSCN, conc. HCl,
MeCN, reflux; b) KH, nBuI, THF, 79% (2 steps); c) tBuLi, CuCN·2 LiCl, THF, À788C,
then BrCH2CCSiMe3, À788C to RT, 94%; d) Raney Ni, acetone/EtOH (1:1), reflux, 92%;
e) AgOTf, CH2Cl2/MeOH/H2O (7:4:1), 73%; f) nBu3SnH, AIBN, 708C, 88%; g) [PdCl2-
(MeCN)2] (3 mol%), DMF, 79%; h) 47% HF/MeCN, then recrystallization; i) LiOH,
THF/MeOH/H2O (3:1:1); j) Ac2O, pyridine, then sat. NaHCO3, aq MeOH, 80%
(3 steps); k) 2, DBU, CH2Cl2, add to the mixed anhydride (1, BOPCl, Et3N, CH2Cl2),
60%; l) LiOH (10 equiv), THF/H2O (3:1), then 1m HCl, 59%. AIBN=2,2’-azobisisobu-
tyronitrile, DBU=1,8-diazabicyclo[5.4.0]undec-7-ene, BOPCl=bis(2-oxo-3-oxazolidinyl)-
phosphinic chloride.
[13]When the iodination of 10 was carried out using
I2 (1 equiv) and AgNO3 (1 equiv) in EtOH at
room temperature, the corresponding Z isomer
was obtained exclusively in 50% yield.
previous synthetic route,[4] condensation of 1 with the free
[14]R. Heckendorn, Helv. Chim. Acta 1990, 73, 1700 – 1718.
[15]X. Liu, J. R. Deschamp, J. M. Cook, Org. Lett. 2002, 4, 3339 –
3342.
[16]The NOESY spectrum was recorded in [D 8]THF/D2O (3:1),
which was the same solvent system as that employed for the
osmylation.
[17]Conformer 17 was suggested to be the energetically most stable
by Molecular mechanics calculations (MMFF, Macro Model
8.5).
[18]T. Fujisawa, T. Mori, T. Sato, Chem. Lett. 1983, 835 – 838.
[19]CCDC-643979 contains the supplementary crystallographic data
for this paper. These data can be obtained free of charge from
cam.ac.uk/data_request/cif.
amine generated in situ from 2 followed by deacetylation of
26 furnished neooxazolomycin, which was identical with a
natural specimen by spectroscopic (1H and 13C NMR) and
chromatographic (TLC and HPLC) comparisons.
In conclusion, neooxazolomycin has been synthesized by a
convergent strategy that features a highly stereoselective
approach involving Tamao hydrosilylation, palladium-cata-
lyzed enolate alkenylation, dihydroxylation accompanied by
lactonization, and a Nozaki–Hiyama–Kishi reaction to con-
struct the right-hand segment 2 and an improved assembly of
the left-hand segment 1. Application of this methodology to
the synthesis of other oxazolomycins is currently under
investigation.
[20]Prepared by Takai–Utimoto olefination of ( E)-4-(Fmoc)amino-
but-2-enal; see the Supporting Information and also K. Takai, K.
Nitta, K. Utimoto, J. Am. Chem. Soc. 1986, 108, 7408 – 7410.
[21]J. S. Panek, P. Liu, J. Am. Chem. Soc. 2000, 122, 11090 – 11097.
[22]Y. Watanabe, WO 2003006422.
Received: May 21, 2007
Published online: July 31, 2007
[23]a) C. M. Shafer, T. F. Molinsky, J. Org. Chem. 1998, 63, 551 – 555;
b) J. P. Marino, H. N. Nguyen, Tetrahedron Lett. 2003, 44, 7395 –
7398.
[24]Prepared by a modified Kende procedure, where the method for
the preparation of (Z)-2-methyl-5-(trimethylsilyl)pent-2-en-4-
ynal, required for the key aldol reaction, was highly improved;
see the Supporting Information.
Keywords: alkaloids · antibiotics · natural products ·
total synthesis
.
Angew. Chem. Int. Ed. 2007, 46, 6703 –6705
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim